UniProtKB/Swiss-Prot A6NK06: Variant p.Thr97Met

Cis-aconitate decarboxylase
Gene: ACOD1
Feedback?

Variant information Variant position:

97 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Methionine (M) at position 97 (T97M, p.Thr97Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to medium size and hydrophobic (M) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Strongly reduced cis-aconitate decarboxylase activity. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs767323284 [ dbSNP | Ensembl ]

Sequence information Variant position:

97 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

481 The length of the canonical sequence.
Location on the sequence:

PPTYAAFVNGVAIHSMDFDD T WHPATHPSGAVLPVLTALAE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PPTYAAFVNGVAIHSMDFDDTWHPATHPSGAVLPVLTALAE

Mouse                         PPTYAAFVNGVAVHSMDFDDTWHPATHPSGAVLPVLTALSE

Caenorhabditis elegans        ---FVLFYEAACVFSN-----FYPSGFEAKPVENFLKD-TE

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 481	Cis-aconitate decarboxylase
Mutagenesis	93 – 93	D -> A. Abolished cis-aconitate decarboxylase activity.
Mutagenesis	97 – 97	T -> A. Strongly reduced cis-aconitate decarboxylase activity.
Mutagenesis	103 – 103	H -> A. Abolished cis-aconitate decarboxylase activity.

Literature citations
Crystal structure of cis-aconitate decarboxylase reveals the impact of naturally occurring human mutations on itaconate synthesis.
Chen F.; Lukat P.; Iqbal A.A.; Saile K.; Kaever V.; van den Heuvel J.; Blankenfeldt W.; Buessow K.; Pessler F.;
Proc. Natl. Acad. Sci. U.S.A. 116:20644-20654(2019)
Cited for: X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) OF 4-461; FUNCTION; CATALYTIC ACTIVITY; BIOPHYSICOCHEMICAL PROPERTIES; SUBUNIT; MUTAGENESIS OF ASP-93; THR-97; HIS-103; HIS-159; LYS-207; LYS-272; HIS-277 AND TYR-318; VARIANTS MET-97; SER-152; ARG-159; GLN-159; GLN-272; HIS-273; TYR-277 AND HIS-331; CHARACTERIZATION OF VARIANTS MET-97; SER-152; ARG-159; GLN-159; GLN-272; HIS-273; TYR-277 AND HIS-331;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.